Cargando…

SARS-COV-2: is it a risk for blood transfusion?

Detalles Bibliográficos
Autores principales:	Langhi, Dante Mário, de Souza, Renato Cerqueira, Barros, Melca, De Santis, Gil Cunha, Kashima, Simone Haddad, Bordin, Jose Orlando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Hematologia e Hemoterapia 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407947/ https://www.ncbi.nlm.nih.gov/pubmed/34485826 http://dx.doi.org/10.1016/j.htct.2021.08.001

Ejemplares similares

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Guidelines on transfusion of red blood cells: Prognosis of patients who decline blood transfusions
por: Langhi, Dante Mário, et al.
Publicado: (2018)

Reduction of exposure to blood donors in preterm infants submitted to red blood cell transfusions using pediatric satellite packs
por: Uezima, Cristina Lika, et al.
Publicado: (2013)

TRANSFUSÃO DE HEMOCOMPONENTES DE DOADORA POSITIVO PARA COVID-19 EM DUAS PACIENTES IMUNODEPRIMIDAS
por: Langhi, D.M., et al.
Publicado: (2020)

Association between Knops blood group polymorphisms and susceptibility to malaria in an endemic area of the Brazilian Amazon
por: Fontes, Aparecida Maria, et al.
Publicado: (2011)

Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia
por: Duarte, Gustavo de Carvalho, et al.
Publicado: (2023)

Alloimmunization screening after transfusion of red blood cells in a prospective study
por: Alves, Vitor Mendonça, et al.
Publicado: (2012)

Blood transfusions in septic shock: is 7.0g/dL really the appropriate threshold?
por: Mazza, Bruno Franco, et al.
Publicado: (2015)

Serological and Molecular Study of the Duffy Blood Group among Malarial Endemic Region Residents in Brazil
por: Langhi, Dante, et al.
Publicado: (2022)

Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19
por: De Santis, Gil Cunha, et al.
Publicado: (2021)

Official communique: Chikungunya virus - a press release of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular regarding the safety of transfusions and transplants
por: Langhi Júnior, Dante, et al.
Publicado: (2014)

BLOOD CELLS PROFILE IN UMBILICAL CORD OF LATE PRETERM AND TERM NEWBORNS
por: Rolim, Anna Carolina Boni, et al.
Publicado: (2019)

Blood donation, blood supply, iron deficiency and anemia - it is time to shift attention back to donor health
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2012)

Low risk of SARS-CoV-2 in blood transfusion
por: Owusu, Michael, et al.
Publicado: (2021)

Association of preoperative anemia and increased risk of blood transfusion and length of hospital stay in adults undergoing hip and knee arthroplasty: An observational study in a single tertiary center
por: Duarte, Gustavo de Carvalho, et al.
Publicado: (2021)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control
por: De Santis, Gil Cunha, et al.
Publicado: (2021)

Guidelines on Beta-thalassemia major – regular blood transfusion therapy: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular: project guidelines: Associação Médica Brasileira – 2016
por: Langhi, Dante, et al.
Publicado: (2016)

RHD*weak D type 38: a family study
por: Costa, Sidneia Sanches, et al.
Publicado: (2016)

Kidd system antigens and kidney disease()
por: Barros, Melca Maria Oliveira
Publicado: (2017)

The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil
por: Langhi Junior, Dante Mário, et al.
Publicado: (2021)

Zika virus and its implication in transfusion safety
por: Kashima, Simone, et al.
Publicado: (2016)

Implications of perioperative allogeneic red blood cell transfusion on the immune-inflammatory response
por: Aguilar-Nascimento, José Eduardo, et al.
Publicado: (2021)

Chagas disease: Performance analysis of immunodiagnostic tests anti-Trypanosoma cruzi in blood donors with inconclusive screening results
por: Ferreira-Silva, Márcia M, et al.
Publicado: (2021)

Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies
por: Gambacorti-Passerini, Carlo, et al.
Publicado: (2021)

Clinical characteristics and indications for blood transfusion in patients with SARS-CoV-2 infection
por: Sanz, Cristina, et al.
Publicado: (2022)

Clinical characteristics and indications for blood transfusion in patients with SARS-CoV-2 infection
por: Sanz, Cristina, et al.
Publicado: (2022)

Implementation of a patient blood management program based on a low-income country-adapted clinical decision support system
por: Duarte, Gustavo de Carvalho, et al.
Publicado: (2022)

Is there justification for universal leukoreduction?
por: Mendrone, Alfredo, et al.
Publicado: (2014)

Predictive Factors for Blood Transfusion after Total Knee Arthroplasty
por: Mozella, Alan de Paula, et al.
Publicado: (2021)

Transfusion Practices Committee of a public blood bank network in Minas Gerais, Brazil
por: de Carvalho, Ricardo Vilas Freire, et al.
Publicado: (2012)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process
por: De Santis, Gil Cunha, et al.
Publicado: (2021)

Blood Transfusion
Publicado: (1950)

Transfusion of Blood
Publicado: (1919)

Transfusion of Blood
por: Porter, J. W.
Publicado: (1921)

Blood Transfusion
Publicado: (1951)

Transfusion of Blood
Publicado: (1889)

Transfusion of Blood
por: Graham, James M.
Publicado: (1922)

Blood Transfusion
por: Bates, Imelda, et al.
Publicado: (2009)

Transfusion of Blood
por: Madge, H. M.
Publicado: (1873)

The Transfusion of Blood
por: Noehren, Alfred H.
Publicado: (1915)

Cannot write session to /tmp/vufind_sessions/sess_p09ob9pc4ruuhoujptp39a5f2i